

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cholesterol efflux (GO:0033344) | 9.27324729 |
| 2 | plasma lipoprotein particle remodeling (GO:0034369) | 9.05367915 |
| 3 | protein-lipid complex remodeling (GO:0034368) | 9.05367915 |
| 4 | macromolecular complex remodeling (GO:0034367) | 9.05367915 |
| 5 | negative regulation of lipase activity (GO:0060192) | 8.07712151 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 7.79433975 |
| 7 | negative regulation of cholesterol transport (GO:0032375) | 7.75398026 |
| 8 | negative regulation of sterol transport (GO:0032372) | 7.75398026 |
| 9 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 7.21696275 |
| 10 | plasma lipoprotein particle organization (GO:0071827) | 7.05794840 |
| 11 | plasma lipoprotein particle clearance (GO:0034381) | 6.98674164 |
| 12 | protein-lipid complex subunit organization (GO:0071825) | 6.71991903 |
| 13 | lipoprotein transport (GO:0042953) | 6.62036113 |
| 14 | positive regulation of lipoprotein lipase activity (GO:0051006) | 6.58983826 |
| 15 | positive regulation of triglyceride lipase activity (GO:0061365) | 6.58983826 |
| 16 | regulation of lipoprotein metabolic process (GO:0050746) | 6.56608666 |
| 17 | regulation of lipoprotein particle clearance (GO:0010984) | 5.93310696 |
| 18 | ovulation from ovarian follicle (GO:0001542) | 5.86056993 |
| 19 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.68715224 |
| 20 | protein carboxylation (GO:0018214) | 5.68715224 |
| 21 | cellular response to zinc ion (GO:0071294) | 5.56442141 |
| 22 | transepithelial transport (GO:0070633) | 5.53913027 |
| 23 | regulation of triglyceride metabolic process (GO:0090207) | 5.42722444 |
| 24 | cholesterol transport (GO:0030301) | 5.06438990 |
| 25 | sterol transport (GO:0015918) | 5.06438990 |
| 26 | positive regulation of lipid catabolic process (GO:0050996) | 5.04633292 |
| 27 | negative regulation of lipid catabolic process (GO:0050995) | 5.04250510 |
| 28 | polyol transport (GO:0015791) | 4.95872819 |
| 29 | triglyceride homeostasis (GO:0070328) | 4.85765122 |
| 30 | acylglycerol homeostasis (GO:0055090) | 4.85765122 |
| 31 | lipoprotein metabolic process (GO:0042157) | 4.69335215 |
| 32 | negative regulation of receptor-mediated endocytosis (GO:0048261) | 4.67017334 |
| 33 | removal of superoxide radicals (GO:0019430) | 4.60672430 |
| 34 | cellular response to superoxide (GO:0071451) | 4.60672430 |
| 35 | cellular response to oxygen radical (GO:0071450) | 4.60672430 |
| 36 | neutral lipid catabolic process (GO:0046461) | 4.59748210 |
| 37 | acylglycerol catabolic process (GO:0046464) | 4.59748210 |
| 38 | regulation of cholesterol transport (GO:0032374) | 4.55655856 |
| 39 | regulation of sterol transport (GO:0032371) | 4.55655856 |
| 40 | regulation of fatty acid biosynthetic process (GO:0042304) | 4.43687423 |
| 41 | response to phenylpropanoid (GO:0080184) | 4.26520005 |
| 42 | glial cell proliferation (GO:0014009) | 4.23459287 |
| 43 | positive regulation of triglyceride metabolic process (GO:0090208) | 4.17289045 |
| 44 | regulation of lipoprotein lipase activity (GO:0051004) | 4.11866136 |
| 45 | cholesterol homeostasis (GO:0042632) | 4.08939712 |
| 46 | triglyceride catabolic process (GO:0019433) | 4.06821588 |
| 47 | regulation of lipid catabolic process (GO:0050994) | 4.04291287 |
| 48 | sterol homeostasis (GO:0055092) | 4.01796461 |
| 49 | regulation of cytokine secretion involved in immune response (GO:0002739) | 4.00361885 |
| 50 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.89192496 |
| 51 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.86248300 |
| 52 | sperm capacitation (GO:0048240) | 3.85792192 |
| 53 | negative regulation of fatty acid metabolic process (GO:0045922) | 3.83184075 |
| 54 | progesterone metabolic process (GO:0042448) | 3.81091085 |
| 55 | L-ascorbic acid metabolic process (GO:0019852) | 3.76901539 |
| 56 | positive regulation of steroid metabolic process (GO:0045940) | 3.74055553 |
| 57 | DNA damage response, detection of DNA damage (GO:0042769) | 3.73297971 |
| 58 | glycerolipid catabolic process (GO:0046503) | 3.64792011 |
| 59 | protein kinase C signaling (GO:0070528) | 3.63279724 |
| 60 | phototransduction, visible light (GO:0007603) | 3.59921103 |
| 61 | sulfate transmembrane transport (GO:1902358) | 3.58483379 |
| 62 | retinoid metabolic process (GO:0001523) | 3.56751358 |
| 63 | homocysteine metabolic process (GO:0050667) | 3.53438931 |
| 64 | response to superoxide (GO:0000303) | 3.49487742 |
| 65 | regulation of digestive system process (GO:0044058) | 3.47917224 |
| 66 | response to hydroperoxide (GO:0033194) | 3.41985417 |
| 67 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 3.37338274 |
| 68 | peptide biosynthetic process (GO:0043043) | 3.33112751 |
| 69 | negative regulation of gluconeogenesis (GO:0045721) | 3.32692920 |
| 70 | SMAD protein signal transduction (GO:0060395) | 3.31152795 |
| 71 | diterpenoid metabolic process (GO:0016101) | 3.29412990 |
| 72 | vitamin A metabolic process (GO:0006776) | 3.28798621 |
| 73 | phospholipid transport (GO:0015914) | 3.26402921 |
| 74 | peripheral nervous system axon ensheathment (GO:0032292) | 3.24383930 |
| 75 | myelination in peripheral nervous system (GO:0022011) | 3.24383930 |
| 76 | response to oxygen radical (GO:0000305) | 3.23900439 |
| 77 | bile acid and bile salt transport (GO:0015721) | 3.17329332 |
| 78 | negative regulation of lipid transport (GO:0032369) | 3.12488271 |
| 79 | regulation of Rho protein signal transduction (GO:0035023) | 3.11778161 |
| 80 | phospholipid homeostasis (GO:0055091) | 3.11380451 |
| 81 | positive regulation of Rho protein signal transduction (GO:0035025) | 3.11053961 |
| 82 | phototransduction (GO:0007602) | 3.10365605 |
| 83 | detection of visible light (GO:0009584) | 3.07152026 |
| 84 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.99884098 |
| 85 | oligosaccharide catabolic process (GO:0009313) | 2.98968931 |
| 86 | sulfate transport (GO:0008272) | 2.98280547 |
| 87 | hydrogen peroxide catabolic process (GO:0042744) | 2.97889076 |
| 88 | organic hydroxy compound transport (GO:0015850) | 2.92789278 |
| 89 | vitamin D metabolic process (GO:0042359) | 2.89762693 |
| 90 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 2.89721937 |
| 91 | terpenoid metabolic process (GO:0006721) | 2.89170164 |
| 92 | sulfation (GO:0051923) | 2.89153292 |
| 93 | phospholipid efflux (GO:0033700) | 14.9537690 |
| 94 | high-density lipoprotein particle remodeling (GO:0034375) | 14.3167899 |
| 95 | regulation of triglyceride catabolic process (GO:0010896) | 13.3835115 |
| 96 | reverse cholesterol transport (GO:0043691) | 12.2680613 |
| 97 | plasma lipoprotein particle assembly (GO:0034377) | 12.0342416 |
| 98 | very-low-density lipoprotein particle assembly (GO:0034379) | 11.0735801 |
| 99 | protein-lipid complex assembly (GO:0065005) | 10.8615996 |
| 100 | regulation of cholesterol esterification (GO:0010872) | 10.4676677 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GATA1_22025678_ChIP-Seq_K562_Human | 6.74072683 |
| 2 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 5.27345431 |
| 3 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 5.12185940 |
| 4 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.04424282 |
| 5 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.65209432 |
| 6 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 4.22645557 |
| 7 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.81932310 |
| 8 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 3.35844900 |
| 9 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.28978760 |
| 10 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.23105331 |
| 11 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.86333098 |
| 12 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.66340123 |
| 13 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.56772698 |
| 14 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.40368944 |
| 15 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.35197544 |
| 16 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.33258057 |
| 17 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.26558680 |
| 18 | TP53_16413492_ChIP-PET_HCT116_Human | 2.09335626 |
| 19 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.85092606 |
| 20 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.73519116 |
| 21 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.72567655 |
| 22 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.63422856 |
| 23 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.62924496 |
| 24 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.59233080 |
| 25 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.57992252 |
| 26 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.54930460 |
| 27 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.48288876 |
| 28 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.42444403 |
| 29 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 1.36954081 |
| 30 | VDR_22108803_ChIP-Seq_LS180_Human | 1.34894426 |
| 31 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.31153559 |
| 32 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.30396218 |
| 33 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.30259593 |
| 34 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.24340151 |
| 35 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.24340151 |
| 36 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.24192237 |
| 37 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.20406988 |
| 38 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.20304750 |
| 39 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.17340540 |
| 40 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.15476545 |
| 41 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.15348265 |
| 42 | P68_20966046_ChIP-Seq_HELA_Human | 1.11882255 |
| 43 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.11846347 |
| 44 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.11614187 |
| 45 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.11390518 |
| 46 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.10359801 |
| 47 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09572204 |
| 48 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.09323656 |
| 49 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.09009648 |
| 50 | P300_27268052_Chip-Seq_Bcells_Human | 1.06565831 |
| 51 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.05923265 |
| 52 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.99883012 |
| 53 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.99783233 |
| 54 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.98413169 |
| 55 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.97065620 |
| 56 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.96910982 |
| 57 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.96592089 |
| 58 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.95253615 |
| 59 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.93860958 |
| 60 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.93331794 |
| 61 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.93223322 |
| 62 | SA1_27219007_Chip-Seq_Bcells_Human | 0.92420628 |
| 63 | CBP_21632823_ChIP-Seq_H3396_Human | 0.91748319 |
| 64 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.91347480 |
| 65 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.87223139 |
| 66 | NCOR_22424771_ChIP-Seq_293T_Human | 0.85477803 |
| 67 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.85293667 |
| 68 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.85293667 |
| 69 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.84635336 |
| 70 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.83878592 |
| 71 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.83082913 |
| 72 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.82979640 |
| 73 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.82310801 |
| 74 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.82203442 |
| 75 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.82041831 |
| 76 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.80736009 |
| 77 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.79090944 |
| 78 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.78148998 |
| 79 | RXR_22108803_ChIP-Seq_LS180_Human | 0.76741381 |
| 80 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.76033510 |
| 81 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.75954113 |
| 82 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.75911880 |
| 83 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.75330897 |
| 84 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.74698837 |
| 85 | * TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.74177762 |
| 86 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.73606931 |
| 87 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.73524021 |
| 88 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.73052094 |
| 89 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.72814601 |
| 90 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.72359791 |
| 91 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.72100492 |
| 92 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.71371568 |
| 93 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.71299568 |
| 94 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.70684693 |
| 95 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.70524376 |
| 96 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.69499526 |
| 97 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.69276840 |
| 98 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.69057945 |
| 99 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 0.68670860 |
| 100 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.67219469 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 7.30525862 |
| 2 | MP0004270_analgesia | 4.49825945 |
| 3 | MP0005377_hearing/vestibular/ear_phenot | 3.33973931 |
| 4 | MP0003878_abnormal_ear_physiology | 3.33973931 |
| 5 | MP0010329_abnormal_lipoprotein_level | 3.04308044 |
| 6 | MP0002876_abnormal_thyroid_physiology | 2.82136983 |
| 7 | MP0004019_abnormal_vitamin_homeostasis | 2.67554212 |
| 8 | MP0004145_abnormal_muscle_electrophysio | 2.29482941 |
| 9 | MP0002254_reproductive_system_inflammat | 2.20454154 |
| 10 | MP0003191_abnormal_cellular_cholesterol | 2.10954087 |
| 11 | MP0009840_abnormal_foam_cell | 14.6584794 |
| 12 | MP0002822_catalepsy | 1.91220327 |
| 13 | MP0005332_abnormal_amino_acid | 1.69470791 |
| 14 | MP0001666_abnormal_nutrient_absorption | 1.63654508 |
| 15 | MP0003136_yellow_coat_color | 1.54398586 |
| 16 | MP0002734_abnormal_mechanical_nocicepti | 1.47468476 |
| 17 | MP0004233_abnormal_muscle_weight | 1.43656259 |
| 18 | MP0000372_irregular_coat_pigmentation | 1.36341307 |
| 19 | MP0005551_abnormal_eye_electrophysiolog | 1.27691658 |
| 20 | MP0006072_abnormal_retinal_apoptosis | 1.26658161 |
| 21 | MP0004142_abnormal_muscle_tone | 1.24846782 |
| 22 | MP0005409_darkened_coat_color | 1.19835996 |
| 23 | MP0009643_abnormal_urine_homeostasis | 1.17702140 |
| 24 | MP0003690_abnormal_glial_cell | 1.16640527 |
| 25 | MP0003718_maternal_effect | 1.16316038 |
| 26 | MP0005171_absent_coat_pigmentation | 1.13562287 |
| 27 | MP0004264_abnormal_extraembryonic_tissu | 1.12334922 |
| 28 | MP0002295_abnormal_pulmonary_circulatio | 1.04719034 |
| 29 | MP0001958_emphysema | 1.03074196 |
| 30 | MP0000566_synostosis | 0.99683620 |
| 31 | MP0004147_increased_porphyrin_level | 0.92719787 |
| 32 | MP0000516_abnormal_urinary_system | 0.92536780 |
| 33 | MP0005367_renal/urinary_system_phenotyp | 0.92536780 |
| 34 | MP0005365_abnormal_bile_salt | 0.91357641 |
| 35 | MP0002909_abnormal_adrenal_gland | 0.89446667 |
| 36 | MP0002118_abnormal_lipid_homeostasis | 0.87924063 |
| 37 | MP0000604_amyloidosis | 0.85558553 |
| 38 | MP0005636_abnormal_mineral_homeostasis | 0.84760167 |
| 39 | MP0002557_abnormal_social/conspecific_i | 0.84625134 |
| 40 | MP0000249_abnormal_blood_vessel | 0.81369340 |
| 41 | MP0005164_abnormal_response_to | 0.79140117 |
| 42 | MP0005448_abnormal_energy_balance | 0.77914634 |
| 43 | MP0005058_abnormal_lysosome_morphology | 0.76029194 |
| 44 | MP0002090_abnormal_vision | 0.74277535 |
| 45 | MP0001919_abnormal_reproductive_system | 0.74258444 |
| 46 | MP0001485_abnormal_pinna_reflex | 0.72839584 |
| 47 | MP0008875_abnormal_xenobiotic_pharmacok | 0.70854994 |
| 48 | MP0005389_reproductive_system_phenotype | 0.68239332 |
| 49 | MP0000920_abnormal_myelination | 0.65806270 |
| 50 | MP0005085_abnormal_gallbladder_physiolo | 0.63057331 |
| 51 | MP0003632_abnormal_nervous_system | 0.60901126 |
| 52 | MP0000003_abnormal_adipose_tissue | 0.60000202 |
| 53 | MP0000639_abnormal_adrenal_gland | 0.59808681 |
| 54 | MP0009642_abnormal_blood_homeostasis | 0.57096022 |
| 55 | MP0004883_abnormal_blood_vessel | 0.56712025 |
| 56 | MP0001756_abnormal_urination | 0.52999773 |
| 57 | MP0001188_hyperpigmentation | 0.52399530 |
| 58 | MP0001299_abnormal_eye_distance/ | 0.52188824 |
| 59 | MP0006082_CNS_inflammation | 0.51884805 |
| 60 | MP0002139_abnormal_hepatobiliary_system | 0.51430383 |
| 61 | MP0003186_abnormal_redox_activity | 0.50811027 |
| 62 | MP0001293_anophthalmia | 0.49395767 |
| 63 | MP0001177_atelectasis | 0.49138396 |
| 64 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.47857160 |
| 65 | MP0003879_abnormal_hair_cell | 0.45565575 |
| 66 | MP0001119_abnormal_female_reproductive | 0.44813126 |
| 67 | MP0008569_lethality_at_weaning | 0.43863111 |
| 68 | MP0005257_abnormal_intraocular_pressure | 0.43258132 |
| 69 | MP0009115_abnormal_fat_cell | 0.43250516 |
| 70 | MP0001765_abnormal_ion_homeostasis | 0.41992694 |
| 71 | MP0001663_abnormal_digestive_system | 0.40942597 |
| 72 | MP0003953_abnormal_hormone_level | 0.40871521 |
| 73 | MP0010030_abnormal_orbit_morphology | 0.40702544 |
| 74 | MP0002136_abnormal_kidney_physiology | 0.40597830 |
| 75 | MP0002160_abnormal_reproductive_system | 0.39652964 |
| 76 | MP0005464_abnormal_platelet_physiology | 0.39359464 |
| 77 | MP0000427_abnormal_hair_cycle | 0.38191740 |
| 78 | MP0002638_abnormal_pupillary_reflex | 0.37858359 |
| 79 | MP0001986_abnormal_taste_sensitivity | 0.37656893 |
| 80 | MP0005395_other_phenotype | 0.35929220 |
| 81 | MP0002877_abnormal_melanocyte_morpholog | 0.35385284 |
| 82 | MP0000609_abnormal_liver_physiology | 0.35339848 |
| 83 | MP0003123_paternal_imprinting | 0.35243049 |
| 84 | MP0001324_abnormal_eye_pigmentation | 0.34633067 |
| 85 | MP0002970_abnormal_white_adipose | 0.33662614 |
| 86 | MP0002069_abnormal_eating/drinking_beha | 0.32902737 |
| 87 | MP0004043_abnormal_pH_regulation | 0.32053962 |
| 88 | MP0003638_abnormal_response/metabolism_ | 0.31425182 |
| 89 | MP0002089_abnormal_postnatal_growth/wei | 0.31304408 |
| 90 | MP0005670_abnormal_white_adipose | 0.30943796 |
| 91 | MP0003646_muscle_fatigue | 0.30863017 |
| 92 | MP0003634_abnormal_glial_cell | 0.30179349 |
| 93 | MP0005381_digestive/alimentary_phenotyp | 0.29061544 |
| 94 | MP0005408_hypopigmentation | 0.28950592 |
| 95 | MP0001529_abnormal_vocalization | 0.28783190 |
| 96 | MP0002078_abnormal_glucose_homeostasis | 0.28594573 |
| 97 | MP0000681_abnormal_thyroid_gland | 0.28245315 |
| 98 | MP0001764_abnormal_homeostasis | 0.27926224 |
| 99 | MP0003699_abnormal_female_reproductive | 0.27860367 |
| 100 | MP0005174_abnormal_tail_pigmentation | 0.27779835 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypolipoproteinemia (HP:0010981) | 8.43706238 |
| 2 | Malnutrition (HP:0004395) | 7.94235865 |
| 3 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 6.51047487 |
| 4 | Abnormality of pyrimidine metabolism (HP:0004353) | 6.04596088 |
| 5 | Pigmentary retinal degeneration (HP:0001146) | 5.38192124 |
| 6 | Hyperglycinemia (HP:0002154) | 4.84509474 |
| 7 | Hypomagnesemia (HP:0002917) | 4.81688531 |
| 8 | Vacuolated lymphocytes (HP:0001922) | 4.80092885 |
| 9 | Abnormality of macrophages (HP:0004311) | 4.71254780 |
| 10 | Nausea (HP:0002018) | 4.69912139 |
| 11 | Joint hemorrhage (HP:0005261) | 4.58284357 |
| 12 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.45811241 |
| 13 | Tetany (HP:0001281) | 4.14514069 |
| 14 | Abnormality of magnesium homeostasis (HP:0004921) | 4.12889914 |
| 15 | Type 2 muscle fiber atrophy (HP:0003554) | 4.12588868 |
| 16 | Abnormality of the common coagulation pathway (HP:0010990) | 3.79669474 |
| 17 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.76974147 |
| 18 | Hypoplasia of the iris (HP:0007676) | 3.67711990 |
| 19 | Muscle fiber atrophy (HP:0100295) | 3.58012202 |
| 20 | Gingival bleeding (HP:0000225) | 3.53564494 |
| 21 | Congenital sensorineural hearing impairment (HP:0008527) | 3.41773584 |
| 22 | Vitreoretinal degeneration (HP:0000655) | 3.33855392 |
| 23 | Deep venous thrombosis (HP:0002625) | 3.25986026 |
| 24 | Severe visual impairment (HP:0001141) | 3.23577042 |
| 25 | Increased serum ferritin (HP:0003281) | 3.15847984 |
| 26 | Proximal tubulopathy (HP:0000114) | 3.12971162 |
| 27 | Prolonged partial thromboplastin time (HP:0003645) | 3.10755636 |
| 28 | Abnormality of the nasal septum (HP:0000419) | 3.02283986 |
| 29 | Spontaneous abortion (HP:0005268) | 3.01897570 |
| 30 | Hypoalphalipoproteinemia (HP:0003233) | 2.98758062 |
| 31 | Amyloidosis (HP:0011034) | 2.94148127 |
| 32 | Abnormality of glycine metabolism (HP:0010895) | 2.88662548 |
| 33 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.88662548 |
| 34 | Dysostosis multiplex (HP:0000943) | 2.80355313 |
| 35 | Prolonged neonatal jaundice (HP:0006579) | 2.80215793 |
| 36 | Menorrhagia (HP:0000132) | 2.78726923 |
| 37 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.75842030 |
| 38 | Dyschromatopsia (HP:0007641) | 2.74090602 |
| 39 | Hyperglycinuria (HP:0003108) | 2.70635043 |
| 40 | Fatigable weakness (HP:0003473) | 2.70322616 |
| 41 | Abnormality of the neuromuscular junction (HP:0003398) | 2.70322616 |
| 42 | Truncal obesity (HP:0001956) | 2.61691145 |
| 43 | Mitral stenosis (HP:0001718) | 2.60290520 |
| 44 | Retinal atrophy (HP:0001105) | 2.53762364 |
| 45 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.51452295 |
| 46 | Severe Myopia (HP:0011003) | 2.47213315 |
| 47 | Bicornuate uterus (HP:0000813) | 2.46178209 |
| 48 | Delayed CNS myelination (HP:0002188) | 2.41738374 |
| 49 | Abnormality of iron homeostasis (HP:0011031) | 2.38762952 |
| 50 | Arthropathy (HP:0003040) | 2.38130253 |
| 51 | Abnormality of nucleobase metabolism (HP:0010932) | 2.35883924 |
| 52 | Dehydration (HP:0001944) | 2.34618065 |
| 53 | Nonprogressive disorder (HP:0003680) | 2.34422566 |
| 54 | Hyperammonemia (HP:0001987) | 2.33377176 |
| 55 | Vascular calcification (HP:0004934) | 2.31051150 |
| 56 | Stage 5 chronic kidney disease (HP:0003774) | 2.27616634 |
| 57 | Abnormal pancreas size (HP:0012094) | 2.27072010 |
| 58 | Late onset (HP:0003584) | 2.25505608 |
| 59 | Pendular nystagmus (HP:0012043) | 2.24215444 |
| 60 | Fat malabsorption (HP:0002630) | 2.19111561 |
| 61 | High anterior hairline (HP:0009890) | 2.17638179 |
| 62 | Metabolic acidosis (HP:0001942) | 2.12101832 |
| 63 | Partial agenesis of the corpus callosum (HP:0001338) | 2.08857462 |
| 64 | Acanthocytosis (HP:0001927) | 2.07029791 |
| 65 | Choroideremia (HP:0001139) | 2.01970372 |
| 66 | Cardiovascular calcification (HP:0011915) | 2.01475782 |
| 67 | Hypobetalipoproteinemia (HP:0003563) | 14.5600526 |
| 68 | Hyperlipoproteinemia (HP:0010980) | 10.7036795 |
| 69 | Chronic hepatic failure (HP:0100626) | 1.99940226 |
| 70 | Weak cry (HP:0001612) | 1.98610334 |
| 71 | White forelock (HP:0002211) | 1.98447669 |
| 72 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.95110455 |
| 73 | Albinism (HP:0001022) | 1.93820947 |
| 74 | Easy fatigability (HP:0003388) | 1.88430956 |
| 75 | Abolished electroretinogram (ERG) (HP:0000550) | 1.82044554 |
| 76 | Decreased muscle mass (HP:0003199) | 1.81823606 |
| 77 | Microretrognathia (HP:0000308) | 1.80575219 |
| 78 | Joint swelling (HP:0001386) | 1.76170114 |
| 79 | Patchy hypopigmentation of hair (HP:0011365) | 1.74976692 |
| 80 | Short hallux (HP:0010109) | 1.72109713 |
| 81 | Abnormality of the Achilles tendon (HP:0005109) | 1.71514556 |
| 82 | Pancreatitis (HP:0001733) | 1.71275525 |
| 83 | Prenatal maternal abnormality (HP:0002686) | 1.71045131 |
| 84 | Back pain (HP:0003418) | 1.69983905 |
| 85 | Abnormality of chloride homeostasis (HP:0011422) | 1.67636419 |
| 86 | Hepatoblastoma (HP:0002884) | 1.61156725 |
| 87 | Steatorrhea (HP:0002570) | 1.59242885 |
| 88 | Intellectual disability, moderate (HP:0002342) | 1.57825414 |
| 89 | Wide anterior fontanel (HP:0000260) | 1.57171124 |
| 90 | Rhinitis (HP:0012384) | 1.56330375 |
| 91 | Abnormality of vitamin B metabolism (HP:0004340) | 1.56290109 |
| 92 | Macular degeneration (HP:0000608) | 1.54181325 |
| 93 | Papillary thyroid carcinoma (HP:0002895) | 1.52867088 |
| 94 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 1.52772419 |
| 95 | Fused cervical vertebrae (HP:0002949) | 1.50412089 |
| 96 | Progressive visual loss (HP:0000529) | 1.49075490 |
| 97 | Coarse hair (HP:0002208) | 1.46523235 |
| 98 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.45858573 |
| 99 | Stenosis of the external auditory canal (HP:0000402) | 1.44448569 |
| 100 | Abnormality of the prostate (HP:0008775) | 1.43589708 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TESK2 | 5.04085142 |
| 2 | BCKDK | 2.79011913 |
| 3 | MUSK | 11.2149940 |
| 4 | PIK3CG | 10.5157126 |
| 5 | ACVR1B | 1.99000853 |
| 6 | TNIK | 1.89551283 |
| 7 | FGFR2 | 1.87958976 |
| 8 | WNK3 | 1.71852062 |
| 9 | MAP3K12 | 1.24321462 |
| 10 | LMTK2 | 1.09933879 |
| 11 | NLK | 0.78580921 |
| 12 | FGFR4 | 0.72518866 |
| 13 | IRAK2 | 0.66487729 |
| 14 | MARK3 | 0.66443838 |
| 15 | TAF1 | 0.61956015 |
| 16 | PRKCG | 0.61835540 |
| 17 | MYLK | 0.60537728 |
| 18 | NEK9 | 0.58222587 |
| 19 | EPHA4 | 0.55209547 |
| 20 | CDK19 | 0.51768319 |
| 21 | GRK1 | 0.51749593 |
| 22 | NUAK1 | 0.49146471 |
| 23 | NEK1 | 0.48953103 |
| 24 | MAPK11 | 0.48403153 |
| 25 | EPHB1 | 0.44719485 |
| 26 | PBK | 0.44177914 |
| 27 | PDK2 | 0.40051860 |
| 28 | PRKACB | 0.39738531 |
| 29 | NTRK3 | 0.39126642 |
| 30 | CSNK1G2 | 0.36499250 |
| 31 | GRK6 | 0.36420362 |
| 32 | STK24 | 0.35781142 |
| 33 | GRK5 | 0.35695199 |
| 34 | NME1 | 0.35415478 |
| 35 | PRKCE | 0.35203606 |
| 36 | FGFR1 | 0.34922902 |
| 37 | FRK | 0.33808614 |
| 38 | BRD4 | 0.32820793 |
| 39 | LRRK2 | 0.32486047 |
| 40 | EPHA3 | 0.30343312 |
| 41 | TYK2 | 0.30317526 |
| 42 | ABL2 | 0.29438518 |
| 43 | ADRBK2 | 0.28627414 |
| 44 | TXK | 0.28333185 |
| 45 | JAK1 | 0.27106951 |
| 46 | PASK | 0.26768923 |
| 47 | NEK6 | 0.26559086 |
| 48 | PTK2B | 0.26296653 |
| 49 | PIM2 | 0.26064829 |
| 50 | OBSCN | 0.25466763 |
| 51 | MAP3K9 | 0.24255907 |
| 52 | MAP2K6 | 0.23090366 |
| 53 | MAP3K2 | 0.22189007 |
| 54 | MET | 0.20739139 |
| 55 | RIPK1 | 0.20405714 |
| 56 | MKNK2 | 0.19489596 |
| 57 | AKT2 | 0.19359839 |
| 58 | ERBB4 | 0.19230641 |
| 59 | PRKCZ | 0.18603668 |
| 60 | ITK | 0.18466847 |
| 61 | PDPK1 | 0.18393593 |
| 62 | PDK1 | 0.17622969 |
| 63 | PTK2 | 0.15848589 |
| 64 | PRKG2 | 0.15761794 |
| 65 | IRAK4 | 0.15482407 |
| 66 | KDR | 0.15336208 |
| 67 | PRKAA2 | 0.14402512 |
| 68 | CSNK1D | 0.13455810 |
| 69 | ARAF | 0.13369656 |
| 70 | PRKACG | 0.13126792 |
| 71 | PAK3 | 0.13067311 |
| 72 | FGFR3 | 0.11415064 |
| 73 | GSK3A | 0.11360440 |
| 74 | RIPK4 | 0.11047891 |
| 75 | CSF1R | 0.10747616 |
| 76 | IRAK1 | 0.10547696 |
| 77 | PAK4 | 0.09280839 |
| 78 | INSRR | 0.09032697 |
| 79 | ERN1 | 0.08879690 |
| 80 | MTOR | 0.08067868 |
| 81 | FER | 0.07497583 |
| 82 | CSNK2A2 | 0.06920521 |
| 83 | CDK11A | 0.06035958 |
| 84 | NTRK1 | 0.05860277 |
| 85 | MATK | 0.04320145 |
| 86 | PRKCB | 0.04252137 |
| 87 | PRKCA | 0.03922773 |
| 88 | PRKCI | 0.03903455 |
| 89 | INSR | 0.03899451 |
| 90 | PDGFRB | 0.03722407 |
| 91 | CSNK2A1 | 0.03652981 |
| 92 | PDGFRA | 0.03615596 |
| 93 | CDK15 | 0.03252219 |
| 94 | ROCK1 | 0.03110627 |
| 95 | PRKACA | 0.03070054 |
| 96 | EPHA2 | 0.03033622 |
| 97 | CSK | 0.02813974 |
| 98 | SGK494 | 0.02677082 |
| 99 | SGK223 | 0.02677082 |
| 100 | IGF1R | 0.02346258 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 8.03994689 |
| 2 | Galactose metabolism_Homo sapiens_hsa00052 | 4.90404132 |
| 3 | Fat digestion and absorption_Homo sapiens_hsa04975 | 4.22724055 |
| 4 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 4.21264715 |
| 5 | Mineral absorption_Homo sapiens_hsa04978 | 4.18813620 |
| 6 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 3.12258076 |
| 7 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 2.71504003 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.41382255 |
| 9 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.29687644 |
| 10 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.20756972 |
| 11 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.13962438 |
| 12 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.91758745 |
| 13 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.89583163 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.79139831 |
| 15 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.78817644 |
| 16 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.73972558 |
| 17 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.63182938 |
| 18 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.59277749 |
| 19 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.53574463 |
| 20 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.36595134 |
| 21 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.34291945 |
| 22 | Bile secretion_Homo sapiens_hsa04976 | 1.30874061 |
| 23 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.30125516 |
| 24 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.22121367 |
| 25 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.19000325 |
| 26 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.18407206 |
| 27 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.14587717 |
| 28 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.10866048 |
| 29 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.07069534 |
| 30 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.06888234 |
| 31 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.03454100 |
| 32 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.02131224 |
| 33 | Other glycan degradation_Homo sapiens_hsa00511 | 0.93701954 |
| 34 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.90275902 |
| 35 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.86615405 |
| 36 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.85804929 |
| 37 | ABC transporters_Homo sapiens_hsa02010 | 0.83122539 |
| 38 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.79313758 |
| 39 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.79014461 |
| 40 | Retinol metabolism_Homo sapiens_hsa00830 | 0.72297547 |
| 41 | Nicotine addiction_Homo sapiens_hsa05033 | 0.69111617 |
| 42 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.68402295 |
| 43 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.67019158 |
| 44 | Carbon metabolism_Homo sapiens_hsa01200 | 0.65507852 |
| 45 | Salivary secretion_Homo sapiens_hsa04970 | 0.62095416 |
| 46 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.61771097 |
| 47 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.57028750 |
| 48 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.54311814 |
| 49 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.52430233 |
| 50 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.51362256 |
| 51 | Metabolic pathways_Homo sapiens_hsa01100 | 0.50644475 |
| 52 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.48273817 |
| 53 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.46000615 |
| 54 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.44552141 |
| 55 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.40890074 |
| 56 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.40143443 |
| 57 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.40014440 |
| 58 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.39516939 |
| 59 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.35762748 |
| 60 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.35269667 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.33049251 |
| 62 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.31717900 |
| 63 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.31712844 |
| 64 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.31009602 |
| 65 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.30523216 |
| 66 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.29805100 |
| 67 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.28684612 |
| 68 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.27854550 |
| 69 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.27464857 |
| 70 | Histidine metabolism_Homo sapiens_hsa00340 | 0.26937344 |
| 71 | Phototransduction_Homo sapiens_hsa04744 | 0.26922577 |
| 72 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.26777863 |
| 73 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.26303223 |
| 74 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.26204025 |
| 75 | Peroxisome_Homo sapiens_hsa04146 | 0.22705246 |
| 76 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.21534562 |
| 77 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.17937806 |
| 78 | Purine metabolism_Homo sapiens_hsa00230 | 0.17934966 |
| 79 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.17886799 |
| 80 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.17752775 |
| 81 | Lysosome_Homo sapiens_hsa04142 | 0.16098216 |
| 82 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.15064645 |
| 83 | Morphine addiction_Homo sapiens_hsa05032 | 0.12662921 |
| 84 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.11050309 |
| 85 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.10927689 |
| 86 | Circadian rhythm_Homo sapiens_hsa04710 | 0.09476684 |
| 87 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.07692906 |
| 88 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.07304421 |
| 89 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.07009635 |
| 90 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.06602530 |
| 91 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.06602348 |
| 92 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.06349584 |
| 93 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.06081292 |
| 94 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.05678882 |
| 95 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.02915514 |
| 96 | Tight junction_Homo sapiens_hsa04530 | 0.02316300 |
| 97 | Cocaine addiction_Homo sapiens_hsa05030 | 0.02135585 |
| 98 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.01839633 |
| 99 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.01153394 |
| 100 | Folate biosynthesis_Homo sapiens_hsa00790 | -0.0139292 |

